Tigermed Buys Back 1.55 Million A-Shares, Lifts Treasury Stock to 7.43 Million

Bulletin Express06-10 18:23

Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that it repurchased 1,550,700 A-shares on 10 June 2026 via the Shenzhen Stock Exchange. The buyback was executed at prices ranging from RMB 38.22 to RMB 39.50 per share, with a volume-weighted average price of RMB 38.74, for a total consideration of RMB 60.07 million.

Following the transaction, the number of issued shares (excluding treasury shares) fell by 0.21% to 730.47 million. Treasury shares increased to 7.43 million, while total issued shares remained unchanged at 737.90 million.

All repurchased shares are being held as treasury shares; none have been cancelled to date. The company confirmed that the operation complied with the rules of both the Hong Kong Stock Exchange and the Shenzhen Stock Exchange.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment